joint disease News
-
Moebius Medical Announces FDA Clearance of IND Application for Phase IIb Clinical Trial of MM-II, a Novel Treatment for Knee Osteoarthritis Pain
Treatment leverages proprietary liposomes and first-in-class mechanism-of-action to achieve significant, sustainable pain relief Phase IIb study expected to begin enrolling by year-end with initial top-line data anticipated in mid-2022 Israel-based Moebius Medical today announced that the US Food and Drug administration (FDA) has cleared their Investigational New Drug (IND) application to ...
-
Moebius Medical Announces Dosing of First Patient in Global Phase IIb Clinical Trial of MM-II, a Novel Treatment for Knee Osteoarthritis Pain
Global Phase IIb study to enrol approximately 312 patients, each of whom will receive one of three doses of MM-II or placebo Primary endpoint is a reduction in pain from baseline as measured by WOMAC A pain scale at 12 weeks Israel-based Moebius Medical today announced that the first patient has been dosed in its Phase IIb clinical trial of MM-II, a novel candidate for the treatment of pain ...
-
David C. Dvorak Invests $5 Million in THINK Surgical
THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announced the investment of $5 million dollars in THINK Surgical by David Dvorak. This investment was completed through Black Lake Expeditions, LLC, an entity for which Mr. Dvorak serves as managing director. Mr. Dvorak became THINK Surgical’s Executive Chairman of the Board last year following an ...
-
Think Surgical Appoints Park Mehendale as Vice President of Operations
(FREMONT, CA) July 26, 2022?- THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announced the appointment of Parikshit (Park) Mehendale as vice president of operations. Mr. Mehendale brings nearly 20 years of global operations, supply chain, and engineering management experience to the THINK organization. At THINK, Mr. Mehendale will lead supply chain, ...
-
Chris Fronk Promoted to Chief Commercial Officer of THINK Surgical
(FREMONT, CA) July 14, 2022 – THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announced the appointment of Chris Fronk as the Chief Commercial Officer. Mr. Fronk joined THINK Surgical in January 2022 as VP Sales and has added tremendous value to the company in a short period of time. Based on his nearly two decades of experience in selling enabling ...
-
Augurex and Quidel at ACR
Augurex and Quidel are pleased to announce the launch of the JOINTstat® 14-3-3η RUO (research use only) ELISA. This new distribution arrangement will get 14-3-3η testing into the hands of more investigators worldwide, including key opinion leaders and pharmaceutical companies, to advance and grow the body of data for this novel joint damage biomarker in autoimmune diseases. There is ...
-
THINK Surgical and Concordia University Receive NSERC Alliance and MEDTEQ+ 3-Year Grant to Develop Artificial Intelligence for Robotic Surgery
THINK Surgical, Inc., a leading innovator in the field of robotic surgery, is pleased to announce a collaborative project between Concordia University and THINK Surgical funded by the Natural Sciences and Engineering Research Council (NSERC) of Canada and MEDTEQ+. The focus of this project will be on developing advanced image registration algorithms using machine learning and Artificial ...
-
Emovi, Inc. Announces Partnership with Sports Illustrated as Key Sponsor for The Sports Illustrated Awards
Emovi, Inc., a global medical device developer, today announced a partnership with Sports Illustrated as a sponsor of the 2020 Sports Illustrated Awards (SI Awards) The SI Awards will take place in Las Vegas on December 19. Viewers can stream the primetime broadcast live via the Sports Illustrated Facebook page beginning at 7:00 PM ET . The award ceremony will feature special presentations, ...
By Emovi
-
THINK Surgical and Curexo Announce Entry Into Development and Distribution Agreement
(FREMONT, CA) August 1, 2022 – THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announced its entry into a development and distribution agreement with Curexo, Inc., a medical robotics specialist company based in South Korea. THINK and Curexo have a strong working relationship based on historical development collaboration and Curexo distributes ...
-
BRIM Biotechnology, Inc. and Ora, Inc. announce new partnership to accelerate the development of regenerative peptide therapy, BRM421 for Dry Eye Syndrome
BRIM Biotechnology, Inc. (“BRIM”) a clinical-stage company developing novel regenerative therapies in ophthalmology, today announces it has entered into a new strategic partnership with Ora®, Inc. (“ORA”) the world’s leading, ophthalmic research organization, for the late-stage clinical development of lead drug candidate, BRM421, for dry eye syndrome (DES). BRIM ...
-
VeriSIM Life Enters into Collaboration Agreement with Mayo Clinic to Jointly Advance Drug Discovery and Development Programs
VeriSIM Life (VeriSIM) www.verisimlife.com, a leading artificial intelligence (AI)-enabled company providing services to de-risk R&D decision making for breakthrough drug development, today announced that it has entered into a collaboration with Mayo Clinic to improve the preclinical translation of promising drug candidates. “We are excited to expand our common mission and work with ...
By VeriSIM Life
-
Orthocell Board Member Heralded for Lifelong Contribution to Orthopaedics
Orthocell Ltd (ASX: OCC) is today celebrating the lifelong achievements of Professor Lars Lidgren, a Swedish surgeon, researcher, entrepreneur and Orthocell board member, who has been awarded an honorary fellowship by the American College of Surgeons (ACS). Orthocell Managing Director, Paul Anderson, said the fellowship recognises significant milestones in Professor Lidgren’s career, ...
-
VeriSIM Life Named “Predictive Analytics Solution of the Year” by BioTech Breakthrough
VeriSIM Life (VeriSIM) www.verisimlife.com, the leading artificial intelligence (AI)-enabled, unique R&D decisions de-risker for breakthrough drug development, today announced it has been selected as the winner of the “Predictive Analytics Solution of the Year" in the BioTech Breakthrough Awards program conducted by BioTech Breakthrough. Biotech Breakthrough is a leading independent ...
By VeriSIM Life
-
Hyalex Welcomes Chris Cain as VP of Clinical and Regulatory Affairs
Hyalex welcomes executive team member, Chris Cain, serving as Vice President of Clinical and Regulatory Affairs. Chris joins the Hyalex team with an impressive background in leading numerous clinical trials of implanted medical devices and taking innovative technologies through US PMA and international regulatory approvals. Chris provides the experience necessary to bring the HYALEX® ...
-
NIMH Teams up to study ASD rates in Somali-American children
NIMH, along with three other NIH Institutes, will be supporting a joint effort with the Centers for Disease Control and Prevention (CDC) and Autism Speaks, a private advocacy organization, to investigate reports of elevated prevalence of autism spectrum disorders (ASD) among children born to Somali immigrants living in Minneapolis, Minn. At the October 2010 meeting of the Interagency Autism ...
-
Hyalex receives FDA Breakthrough Device Designation for novel HYALEX Cartilage System
Hyalex Orthopaedics, Inc., announced that the HYALEX Cartilage System has been granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). The HYALEX Cartilage System is intended to repair cartilage defects and restore function for patients with loss of knee articular cartilage and bone requiring surgery. Hyalex is currently in the pre-clinical stage of development ...
-
Siveco client GSN fights the COVID-19 epidemic using bluebee®
Fighting the COVID-19 (Corona Virus Disease) epidemic requires joint efforts! GSN Property Services, the leading German property management provider in China, is using bluebee® to monitor progress of disinfection work. Scanning of QR-coded tags in the bluebee® app ensures the traceability of actions taken against the COVID-19. GSN has also deployed the bluebee® system at two ...
By Siveco China
-
Safer Product Groups, manufacturer seek transparency on chemical ingredients
A panel consisting of representatives from environmental groups, consumer advocacy organizations and a sustainable product manufacturer agreed that they would like to see chemical manufacturers fully disclose the ingredients of their products to regulators and the public. Ryan Williams, director of sustainability and so-called good cop at Method, said Sept. 18 that his company supports ...
-
What Are D-Glucosamines?
Glucosamine is a natural component of cartilage and is widely used as an over-the-counter nutritional supplement to reduce the pain and cartilage loss of osteoarthritis. Glucosamine is usually taken in combination with chondroitin, which is a glycosaminoglycan that also exists in cartilage.Glucosamine is an amino sugar and an important molecule in the biochemical pathway of glycosylated protein ...
-
Partners in health and millennium promise join global impact`s alliance of internationally-focused charities
Global Impact, whose mission is to assure help for the world's most vulnerable people, announced today that it has selected Partners In Health and Millennium Promise to join its alliance of internationally-focused charities. Global Impact has raised more than $1.3 billion for relief and development programs since it was founded in 1956. "Partners In Health and Millennium Promise build ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you